Speaker illustration

Doctor Masaaki Nakao

Niigata University Graduate School of Medical and Dental Sciences, Niigata (Japan)

Empagliflozin improves cardiac function through the increased production of acetylcarnitine in a murine non-diabetic heart failure model

Event: ESC Congress 2019

Topic: Drugs, Drug Targets

Session: Pharmacology, angiogenesis and cardiovascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb